COc1ccc2c(c1O)C13CCN(C)C(C2)C1CCC1(C3)OCCO1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?